Five states filed lawsuits against Purdue Pharma on Thursday for contributing to the opioid epidemic via the promotion of its painkiller, OxyContin. Iowa, Kansas, Maryland, West Virginia and Wisconsin are joining 39 other states that have sued the drugmaker. (Reuters)
The Metropolitan Museum of Art will no longer accept gifts from the Sackler family. The Guggenheim and the Tate previously made the same decision due to the Sacklers’ ownership of Purdue Pharma and the 1,600 lawsuits it’s facing over OxyContin. (CNBC)
The Trump administration may require insurers and providers to be more transparent about pricing. Insurers may be required to share negotiated rates for services while providers would need to disclose cost of care before receiving the service. Experts are split on whether these requirements would lower prices with some arguing it may actually cause some prices to increase. (Axios)
Remedy Health has purchased Vertical Health for an undisclosed price. The acquisition will enableRemedy to add condition-specific brands to serve audiences including specialist physicians. (MM&M)
Nestle CEO Mark Schneider is planning to sell the company’s skincare unit for $10.1 billion. The deal, which includes brands such as Cetaphil and Proactiv, is expected to close by the end of the year. It would be the second-largest divestment made by Nestle. (Bloomberg)
